Teil von
Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer.
J Magn Reson Imaging 7(1997): 75–81
2.) Bellin MF, et al.:
Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles – initial clinical experience.
Radiology 207(1998):799–808
3.) Koh DM, et al.:
Rectal cancer: mesorectallymph nodes at MR imaging with USPIO versus histopathologic finding-initial observations.
Radiology 231(2004): 91–99
4.) Mack MG, et al.:
Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.
Radiology 222(2002): 239–244
5.) Weissleder R, et al.:
Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
Radiology 175(1990): 494–498
6.) Deserno WM, et al.:
Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Radiology 233(2004): 449–456
7.) Memarsadeghi M, et al.:
Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus USPIO-enhanced MR imaging.
Radiology 241(2006):367–377
8.) Harisinghani MG, et al.:
Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
Am J Roentgenol 186(2006): 144–148
9.) Nishimura H, et al.:
Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
J Am Coll Surg 202(2006): 604–611
10.) Stets C, et al.:
Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO.
J Magn Reson Imaging 16(2002): 60–68
